CIK 0001574565 · Non-accelerated filer
Evogene Ltd.
Sign in to watch- Ticker
- EVGN
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 97289311900
- Business address
- 13 GAD FEINSTEIN STREET, PARK REHOVOT, REHOVOT, Israel, 7638517
- 4 Open-market buy Chief Development Officer bought 1,129 shares at $0.60 ($677)
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 460,000 shares at $0.64 ($292,100)
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 800,000 shares at $0.50 ($400,000)
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13D Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- 6-K Event Report of Foreign Issuer
Page 2 of 24 · 464 filings